How close is the Ebola vaccine?
Is the world prepared to fight the next Ebola outbreak? NewsHour provides an update on Ebola vaccine testing in West Africa.
Trial Shows First HIV Protection from Vaccines
Promising results released Thursday from an HIV vaccine trial in Thailand show for the first time that a vaccine may prevent HIV infection.
Merck/Schering-Plough Merger Would Create Second-Largest Drug Company
Two major pharmaceutical companies announced plans to merge Monday in a $41.1 billion cash-and-stock deal to form the world's second-largest prescription drug maker.
Greenspan Calls Financial Crisis a ‘Credit Tsunami’
In testimony before Congress Thursday, former Federal Reserve Chair Alan Greenspan said that the current financial crisis is a "once in a century credit tsunami" that will continue to impact the U.S. economy, spurring more job losses to come.
A number of poor earnings reports from major corporations, including Wachovia Corp. and Merck & Co., caused U.S. stocks to drop more than 500 points Wednesday.
Pharmaceutical company Merck knew in 2001 that its arthritis drug Vioxx could harm patients and used staffers to "ghostwrite" favorable research on the drug, articles in the Journal of the American Medical Association report. Susan Dentzer examines the charges.
The makers of the cholesterol drug Vytorin pulled its telelvision ads off the air on Tuesday, after a study found the drug was no more effective at reducing the risk of heart attack than one of its generic counterparts. Two…
An interview with a gynecologist looks at Gardasil, a new vaccine approved by the Food and Drug Administration for use in girls and women to prevent four strains of a virus that can cause cervical cancer.
In an effort to recover from major financial losses sustained by controversy over its bestselling painkiller Vioxx, drugmaker Merck & Co. announced it would cut 7,000 jobs over the next three years and close five of its manufacturing plants.
Additional Support Provided By:
